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Myasthenia Gravis Appearing After Thymectomy: 
a Case Report and Review of the Literature
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A small proportion of thymoma patients without myasthenia gravis (MG) have been observed to develop MG after 
total removal of the thymoma. However, the underlying cause is not yet known due to the rarity of postoperative 
MG patients. We report a 39-year-old man in whom MG appeared after surgical removal of a thymoma. Computed 
tomography and magnetic resonance imaging showed no signs of recurrent or metastatic thymoma. Administration 
of pyridostigmine bromide resulted in the prompt improvement of myasthenic symptoms. Our observations indicate 
that postoperative follow-up care with monitoring of possible postoperative MG is necessary after resecting a 
thymoma.
J Clin Neurol 3(3):158-160, 2007
Key Words : Myasthenia gravis, Thymectomy, Thymoma
Received : May 14, 2007 / Accepted : August 16, 2007 / Address for correspondence : Sa-Yoon Kang, M.D.
Department of Neurology, Cheju National University School of Medicine, 1 Ara 1-dong, Jeju-si, Jeju, 690-756, Korea
Tel: +82-64-754-1107, Fax: +82-64-754-1109, E-mail: neurokang@cheju.ac.kr
Myasthenia gravis (MG) is an autoimmune disease in 
which muscular weakness and fatigability of skeletal 
muscles are caused by an antibody against the acetyl-
choline receptor (AChR) at the neuromuscular junction. 
A thymoma, which is an epithelial tumor of the thymus 
gland that is usually benign, occurs in about 15% of 
adult patients with MG.
1  It has long been suspected that 
the thymus or a thymoma may play a role in the 
pathogenesis of MG. Although thymectomy may improve 
the myasthenic symptoms, MG can develop from months 
to years after the removal of a thymoma in previously 
nonmyasthenic patients.
2-5 A nonresidual tumor or 
thymic tissues have been found in some patients, while 
MG heralded recurrent or metastatic thymoma in 
other cases.
6,7 We defined cases of MG onset after 
total removal of the thymoma as ‘postoperative MG’. 
We report a patient in whom MG appeared after total 
removal of the thymus for thymoma without tumor 
recurrence.
CASE REPORT
A 39-year-old man presented with diplopia and ptosis 
that was characterized by diurnal variation. Three years 
previously a mediastinal tumor was diagnosed on a chest 
X-ray during a routine medical examination. Chest 
computed tomography (CT) confirmed the presence 
of a demarcated anterosuperior mediastinal mass, 
leading to the diagnosis of a thymoma. Anti-AChR 
antibodies were not detected and an electromyogram 
was not performed. At that time the patient was 
asymptomatic, and there were no clinical signs of MG 
before surgery. He received a median sternotomy, and 
an anterosuperior, well-encapsulated tumor was found 
that was not adherent to the mediastinal structures. Total 
resection of the mass and the adjacent thymic tissue was 
performed. Histological examination findings confirmed 
the diagnosis of a noninvasive medullary thymoma. His Kang SY, et al. Myasthenia Gravis Appearing After Thymectomy
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postoperative course was satisfactory. 
On admission, bilateral ptosis and diplopia were 
present, but the physical examination was otherwise 
normal. Results from repetitive nerve stimulation and 
neostigmine tests were consistent with neuromuscular 
junction disorder. The titer of anti-AChR antibody 
was high, at 43.7 nmol/l. The diagnosis of MG was 
confirmed by the findings of both the anti-AChR 
antibody and electrophysiological test. Chest CT and 
magnetic resonance imaging showed no signs of recurrent 
or metastatic thymoma. Pyridostigmine bromide admini-
stration (180 mg per day) was started, which resulted in 
the prompt improvement of myasthenic symptoms. 
At a 2-year follow-up, the patient was doing well on 
pyridostigmine, with a chest CT revealing no evidence 
of a recurrent or metastatic tumor.
DISCUSSION
The thymus plays a key role in the immunologic 
status of an individual, and disease of the thymus 
can be associated with autoimmune disorders. MG first 
appearing many years following the removal of a 
thymoma reportedly occurs in 1.5-28% of cases.
8 The 
interval between a thymectomy and the onset of 
postoperative MG has varied between studies. Two 
of the studies involving an adequate number of cases 
and obtaining detailed clinical data found that the 
mean interval between thymectomy and the onset of 
postoperative MG was 19 and 18 months. Namba et al. 
reported that patients with a shorter onset of post-
operative MG had a better prognosis, but other study did 
not find this relationship.
3,8 The rarity of postoperative 
MG cases has meant that it remains unclear whether the 
interval between thymectomy and the onset of post-
operative MG influences the prognosis. We speculate 
that this discrepancy is due to different therapies being 
applied for MG. Most reports demonstrate that post-
operative MG responds to anticholinesterase drugs and/or 
steroids, and that the prognosis is relatively good.
5,8 
Although a thymectomy does not prevent the onset 
of postoperative MG, this procedure is associated with 
a good prognosis.
One study found that 63%, 25%, and 12% of thymo-
mas were of mixed histological type, predominantly 
lymphocytic type, and predominantly epithelial type, 
respectively,
3 and the corresponding percentages in 
another study were 65%, 22%, and 13%.
8 These distri-
butions of the histological types were similar to that 
in patients with thymoma and preoperative MG. In 
the study of Kondo and Monden, the anti-AChR 
antibody at onset varied between 1.8 and 91 nmol/l.
8 
The majority of patients show a clinical severity of 
type I or type IIA on Osserman’s classification. How-
ever, they found that the titer of anti-AChR antibody 
did not correlate with clinical severity, as was the case 
in our patient.
The mechanism underlying the onset of postoperative 
MG is unclear. The various time periods between a 
thymectomy and the onset of postoperative MG raise 
doubts as to whether a thymectomy directly triggers 
MG onset. Two useful studies were recently published. 
Hoffacker et al. found using T-cell-proliferation assays 
for a fragment of the AChR that the thymoma released 
mature auto-antigen-specific T-cells into the periphery.
9 
Buckley et al. found that T-cells in a thymoma were 
exported to the peripheral blood, and that these T-cells 
could persist in the periphery for many years.
10 These 
studies suggest that a thymoma actively exports large 
numbers of mature T-cells into the peripheral blood, 
with these cells persisting in the periphery, potentially 
stimulating autoantibody production and subsequent 
autoimmune disease.
The late onset of MG and other autoimmune disorders 
should be kept in mind as possible complications of 
surgical treatment for thymoma. Therefore postoperative 
follow-up care with consideration of postoperative MG 
is necessary after resecting a thymoma. In postoperative 
MG cases, recurrent or metastatic thymoma should be 
ruled out because reoperation can be effective even in 
the treatment of MG.
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